AVROBIO, Inc.

AVROBIO, Inc.verified

AVRO

Price:

$1.51

Market Cap:

$67.79M

AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's product includes AVR-RD-01, a gene therapy for the treatment of Fabry disease. It is also developing AVR-RD-02, which is in phase 1/2 clinical trial for the treatment of type 1 Gaucher disease; AVR-RD-03, for the treatment of Pompe disease; AVR-RD-04 for the treatment of cystinosis; AVR-RD-05 for the treatment of Hunter ...[Read more]

Industry

Biotechnology

IPO Date

2018-06-21

Stock Exchange

NASDAQ

Ticker

AVRO

The PE Ratio as of May 2024 (TTM) for AVROBIO, Inc. (AVRO) is 5.59

According to AVROBIO, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 5.59. This represents a change of -599.92% compared to the average of -1.12 of the last 4 quarters.

AVROBIO, Inc. (AVRO) Historical PE Ratio (quarterly & annually)

How has AVRO PE Ratio performed in the past?

The mean historical PE Ratio of AVROBIO, Inc. over the last ten years is -10.86. The current 5.59 PE Ratio has changed -5248.09% with respect to the historical average. Over the past ten years (40 quarters), AVRO's PE Ratio was at its highest in in the December 2022 quarter at 0.24. The PE Ratio was at its lowest in in the March 2017 quarter at -60.79.

Quarterly (TTM)
Annual

Average

-10.86

Median

-4.54

Minimum

-46.31

Maximum

4.96

AVROBIO, Inc. (AVRO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of AVROBIO, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 58.70%

Maximum Annual PE Ratio = 4.96

Minimum Annual Increase = -1793.37%

Minimum Annual PE Ratio = -46.31

Quarterly (TTM)
Annual
YearPE RatioChange
20234.96-1793.37%
2022-0.29-79.10%
2021-1.40-67.09%
2020-4.26-44.38%
2019-7.6658.70%
2018-4.83-82.18%
2017-27.08-41.51%

AVROBIO, Inc. (AVRO) Average PE Ratio

How has AVRO PE Ratio performed in the past?

The current PE Ratio of AVROBIO, Inc. (AVRO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

1.09

5-year avg

-1.73

10-year avg

-10.86

AVROBIO, Inc. (AVRO) PE Ratio vs. Peers

How is AVRO’s PE Ratio compared to its peers?

AVROBIO, Inc.’s PE Ratio is greater than CohBar, Inc. (-0.25), greater than Ocean Biomedical, Inc. (-0.25), greater than Enveric Biosciences, Inc. (-0.22), greater than Elevation Oncology, Inc. (-4.62), greater than Zura Bio Limited (-5.00), greater than Hepion Pharmaceuticals, Inc. (-0.15), greater than eFFECTOR Therapeutics, Inc. (-0.21),

Build a custom stock screener for AVROBIO, Inc. (AVRO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AVROBIO, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AVROBIO, Inc. (AVRO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AVROBIO, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is AVROBIO, Inc.'s PE Ratio?

How is the PE Ratio calculated for AVROBIO, Inc. (AVRO)?

What is the highest PE Ratio for AVROBIO, Inc. (AVRO)?

What is the 3-year average PE Ratio for AVROBIO, Inc. (AVRO)?

What is the 5-year average PE Ratio for AVROBIO, Inc. (AVRO)?

How does the current PE Ratio for AVROBIO, Inc. (AVRO) compare to its historical average?